It’s high school all over again for new drug approvals.
The Food & Drug Administration is proposing the development of a pilot program to assess and communicate post-marketing experience for...
Making the Grade: Reviving the New Drug "Report Card"
The Food & Drug Administration is proposing the development of a pilot program to assess and communicate post-marketing experience for newly approved drugs and biologics. The pilot, which is part of FDA's response to the Institute of Medicine report on drug safety, is a revival of the "report card" idea from the late 1990s.